Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo

References

• Molina-Holgado F, Doherty P, Williams G. Tandem repeat peptide strategy for the design of neurotrophic factor mimetics. CNS Neurol Disord Drug Targets. 2008;7(1):110–119. doi:10.2174/18715270878388520018289037
   PubMedGoogle Scholar
• Scott-Solomon E, Kuruvilla R. Mechanisms of neurotrophin trafficking via Trk receptors. Mol Cell Neurosci. 2018;91:25–33. doi:10.1016/j.mcn.2018.03.01329596897
   PubMedGoogle Scholar
• Machalinska A, Kawa M, Pius-Sadowska E, et al. Long-term neuroprotective effects of NT-4-engineered mesenchymal stem cells injected intravitreally in a mouse model of acute retinal injury. Invest Ophthalmol Vis Sci. 2013;54(13):8292–8305. doi:10.1167/iovs.13-1222124265016
   PubMedGoogle Scholar
• BDNF study group (phase III). A controlled trial of recombinant methionyl human BDNF in ALS.Neurology. 1999;52(7):1427–1433. doi:10.1212/WNL.52.7.142710227630
   PubMed Web of Science ®Google Scholar
• Geral C, Angelova A, Lesieur S. From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics. 2013;5(1):127–167. doi:10.3390/pharmaceutics501012724300402
   PubMedGoogle Scholar
• Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14(1):7–23. doi:10.1038/nrn337923254191
   PubMed Web of Science ®Google Scholar
• Weissmiller AM, Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders. Transl Neurodegener. 2012;1(1):14. doi:10.1186/2047-9158-1-1423210531
   PubMedGoogle Scholar
• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138(2):155–175. doi:10.1016/j.pharmthera.2013.01.00423348013
   PubMed Web of Science ®Google Scholar
• Iezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials. 2012;33(3):979–988. doi:10.1016/j.biomaterials.2011.10.01022048009
   PubMed Web of Science ®Google Scholar
• LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A. 1992;89(23):11249–11253. doi:10.1073/pnas.89.23.112491454803
   PubMed Web of Science ®Google Scholar
• Paskowitz DM, Donohue-Rolfe KM, Yang H, et al. Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy. Invest Ophthalmol Vis Sci. 2007;48(1):430–437. doi:10.1167/iovs.06-069017197564
   PubMedGoogle Scholar
• Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol. 2013;156(2):283–292.e1. doi:10.1016/j.ajo.2013.03.02123668681
   PubMedGoogle Scholar
• El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases: from basic considerations to clinical applications. Prog Retin Eye Res. 2010;29(6):443–465. doi:10.1016/j.preteyeres.2010.04.00120398784
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13(3–4):144–151. doi:10.1016/j.drudis.2007.10.02118275912
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013;39(11):1599–1617. doi:10.3109/03639045.2012.73651523153114
   PubMed Web of Science ®Google Scholar
• McNerny DQ, Leroueil PR, Baker JR. Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(3):249–259. doi:10.1002/wnan.7920166124
   PubMedGoogle Scholar
• Quintana A, Raczka E, Piehler L, et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res. 2002;19(9):1310–1316.12403067
   PubMed Web of Science ®Google Scholar
• Thomas TP, Majoros IJ, Kotlyar A, et al. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem. 2005;48(11):3729–3735. doi:10.1021/jm040187v15916424
   PubMedGoogle Scholar
• Mignani S, El Kazzouli S, Bousmina M, Majoral JP. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Adv Drug Deliv Rev. 2013;65(10):1316–1330. doi:10.1016/j.addr.2013.01.00123415951
   PubMed Web of Science ®Google Scholar
• Leroueil PR, Berry SA, Duthie K, et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 2008;8(2):420–424. doi:10.1021/nl072292918217783
   PubMed Web of Science ®Google Scholar
• Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release. 2000;65(1–2):133–148.10699277
   PubMed Web of Science ®Google Scholar
• Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D’Emanuele A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm. 2003;252(1–2):263–266.12550802
   PubMed Web of Science ®Google Scholar
• Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res. 1996;30(1):53–65. doi:10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q8788106
   PubMed Web of Science ®Google Scholar
• Das AK, Hsiao PY. Charged dendrimers in trivalent salt solutions under the action of DC electric fields. J Phys Chem B. 2014;118(23):6265–6276. doi:10.1021/jp411658924837658
   PubMedGoogle Scholar
• Tokarczyk K, Jachimska B. Quantitative interpretation of PAMAM dendrimers adsorption on silica surface. J Colloid Interface Sci. 2017;503:86–94. doi:10.1016/j.jcis.2017.05.00228500943
   PubMedGoogle Scholar
• Jachimska B, Lapczynska M, Zapotoczny S. Reversible swelling process of sixth-generation Poly(amido amine) dendrimers molecule as determined by quartz crystal microbalance technique. J Phys Chem C. 2013;117(2):1136–1145. doi:10.1021/jp307832p
   Web of Science ®Google Scholar
• Porus M, Clerc F, Maroni P, Borkovec M. Ion-specific responsiveness of polyamidoamine (PAMAM) dendrimers adsorbed on silica substrates. Macromolecules. 2012;45(9):3919–3927. doi:10.1021/ma3004295
   Web of Science ®Google Scholar
• Welch P, Muthukumar M. Tuning the density profile of dendritic polyelectrolytes. Macromolecules. 1998;31(17):5892–5897. doi:10.1021/ma980198w
   Web of Science ®Google Scholar
• Li N, Cai H, Jiang L, et al. Enzyme-Sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy. ACS Appl Mater Interfaces. 2017;9(8):6865–6877. doi:10.1021/acsami.6b1550528112512
   PubMed Web of Science ®Google Scholar
• Lamy CM, Sallin O, Loussert C, Chatton JY. Sodium sensing in neurons with a dendrimer-based nanoprobe. ACS Nano. 2012;6(2):1176–1187. doi:10.1021/nn203822t22288942
   PubMedGoogle Scholar
• Choi SK, Myc A, Silpe JE, et al. Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano. 2013;7(1):214–228. doi:10.1021/nn303899523259666
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang B, Zhou L, et al. Imaging dendrimer-grafted graphene oxide mediated anti-miR-21 delivery with an activatable luciferase reporter. ACS Appl Mater Interfaces. 2016;8(14):9014–9021. doi:10.1021/acsami.6b0266227010367
   PubMed Web of Science ®Google Scholar
• Cao J, Ge R, Zhang M, et al. A triple modality BSA-coated dendritic nanoplatform for NIR imaging, enhanced tumor penetration and anticancer therapy. Nanoscale. 2018;10(19):9021–9037. doi:10.1039/c7nr09552j29717725
   PubMedGoogle Scholar
• Kim K, Lee J, Jo G, Shin S, Kim JB, Jang JH. Dendrimer-capped gold nanoparticles for highly reliable and robust surface enhanced Raman scattering. ACS Appl Mater Interfaces. 2016;8(31):20379–20384. doi:10.1021/acsami.6b0571027403733
   PubMedGoogle Scholar
• Ma W, Fu F, Zhu J, et al. 64Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging. Nanoscale. 2018;10(13):6113–6124. doi:10.1039/c7nr09269e29547220
   PubMedGoogle Scholar
• Giri J, Diallo MS, Simpson AJ, et al. Interactions of poly(amidoamine) dendrimers with human serum albumin: binding constants and mechanisms. ACS Nano. 2011;5(5):3456–3468. doi:10.1021/nn102100721438566
   PubMedGoogle Scholar
• Curtis RA, Ulrich J, Montaser A, Prausnitz JM, Blanch HW. Protein-protein interactions in concentrated electrolyte solutions. Biotechnol Bioeng. 2002;79(4):367–380. doi:10.1002/bit.1034212115400
   PubMedGoogle Scholar
• Lin YL, Khanafer K, El-Sayed ME. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers. Nanoscale. 2010;2(5):755–762. doi:10.1039/b9nr00407f20648321
   PubMed Web of Science ®Google Scholar
• Yang B, Xu H, Wang S, et al. Studying the dynamic mechanism of transporting a single drug carrier-polyamidoamine dendrimer through cell membranes by force tracing. Nanoscale. 2016;8(42):18027–18031. doi:10.1039/c6nr05838h27734053
   PubMedGoogle Scholar
• Dabkowska M, Adamczyk Z, Cie?la M, Adamczak M, Bober J. Lysozyme monolayers at polymer microparticles: electrokinetic characteristics and modeling. J Phys Chem C. 2018;122(31):17846–17855. doi:10.1021/acs.jpcc.8b04916
   Web of Science ®Google Scholar
• Kujda M, Adamczyk Z, Ciesla M. Monolayers of the HSA dimer on polymeric microparticles-electrokinetic characteristics. Colloids Surf B Biointerfaces. 2016;148:229–237. doi:10.1016/j.colsurfb.2016.08.01727606496
   PubMedGoogle Scholar
• Bratek-Skicki A, Zeliszewska P, Adamczyk Z, Ciesla M. Human fibrinogen monolayers on latex particles: role of ionic strength. Langmuir. 2013;29(11):3700–3710. doi:10.1021/la400419y23421850
   PubMedGoogle Scholar
• Zhenhua XT, Yiyun Cheng X, Minglu M, Peng X, Haiou Q, Wen L. Colorimetric determination of polyamidoamine dendrimers and their derivates using a simple and rapid ninhydrin assay. Anal Lett. 2008;41:444–455. doi:10.1080/00032710701484350
   Web of Science ®Google Scholar
• Adamczyk Z, Bratek-Skicki A, Dabrowska P, Nattich-Rak M. Mechanisms of fibrinogen adsorption on latex particles determined by zeta potential and AFM measurements. Langmuir. 2012;28(1):474–485. doi:10.1021/la203811922026755
   PubMedGoogle Scholar
• Machalinska A, Kawa MP, Pius-Sadowska E, et al. Endogenous regeneration of damaged retinal pigment epithelium following low dose sodium iodate administration: an insight into the role of glial cells in retinal repair. Exp Eye Res. 2013;112:68–78. doi:10.1016/j.exer.2013.04.00423623997
   PubMed Web of Science ®Google Scholar
• Machalinska A, Roginska D, Pius-Sadowska E, et al. Neuroprotective and antiapoptotic activity of lineage-negative bone marrow cells after intravitreal injection in a mouse model of acute retinal injury. Stem Cells Int. 2015;2015:620364. doi:10.1155/2015/62036425810725
   PubMedGoogle Scholar
• Dabkowska M, Adamczak M, Barbasz J, Ciesla M, Machalinski B. Adsorption/desorption transition of recombinant human neurotrophin 4: physicochemical characterization. Langmuir. 2017;33(38):9548–9557. doi:10.1021/acs.langmuir.7b0090928825842
   PubMedGoogle Scholar
• Mullen DG, Fang M, Desai A, Baker JR, Orr BG, Banaszak Holl MM. A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano. 2010;4(2):657–670. doi:10.1021/nn900999c20131876
   PubMedGoogle Scholar
• Wasilewska M, Adamczyk Z, Jachimska B. Structure of fibrinogen in electrolyte solutions derived from dynamic light scattering (DLS) and viscosity measurements. Langmuir. 2009;25(6):3698–3704. doi:10.1021/la803662a19228031
   PubMedGoogle Scholar
• Adamczyk Z, Bratek A, Jachimska B, Jasinski T, Warszynski P. Structure of poly(acrylic acid) in electrolyte solutions determined from simulations and viscosity measurements. J Phys Chem B. 2006;110(45):22426–22435. doi:10.1021/jp063981w17091984
   PubMedGoogle Scholar
• Delgado AV, Gonzalez-Caballero F, Hunter RJ, Koopal LK, Lyklema J. Measurement and interpretation of electrokinetic phenomena. J Colloid Interface Sci. 2007;309(2):194–224. doi:10.1016/j.jcis.2006.12.07517368660
   PubMed Web of Science ®Google Scholar
• Roberts D, Keeling R, Tracka M, et al. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody. Mol Pharm. 2015;12(1):179–193. doi:10.1021/mp500533c25389571
   PubMed Web of Science ®Google Scholar
• Adamczyk Z, Nattich M, Wasilewska M, Zaucha M. Colloid particle and protein deposition - electrokinetic studies. Adv Colloid Interface Sci. 2011;168(1–2):3–28. doi:10.1016/j.cis.2011.04.00221621181
   PubMedGoogle Scholar
• Aubin-Tam ME, Hamad-Schifferli K. Structure and function of nanoparticle-protein conjugates. Biomed Mater. 2008;3(3):034001. doi:10.1088/1748-6041/3/3/03400118689927
   PubMedGoogle Scholar
• Geoghegan WD, Ackerman GA. Adsorption of horseradish peroxidase, ovomucoid and anti-immunoglobulin to colloidal gold for the indirect detection of concanavalin A, wheat germ agglutinin and goat anti-human immunoglobulin G on cell surfaces at the electron microscopic level: a new method, theory and application. J Histochem Cytochem. 1977;25(11):1187–1200. doi:10.1177/25.11.2121721217
   PubMedGoogle Scholar
• Bayraktar H, You CC, Rotello VM, Knapp MJ. Facial control of nanoparticle binding to cytochrome C. J Am Chem Soc. 2007;129(10):2732–2733. doi:10.1021/ja067497i17309259
   PubMedGoogle Scholar
• Adamczyk Z. Particles at Interfaces. Vol. 20 Amsterdam: Elsevier; 2017:700.
   Google Scholar
• Serra J, Puig J, Martin A, Galisteo F, Galvez J, Hildago-Alvarez R. On the adsorption of IgG onto polystyrene particles: electrophoretic mobility and critical coagulation concentration. Colloid Polym Sci. 1992;270(6):574–583. doi:10.1007/BF00658288
   Web of Science ®Google Scholar
• Bharti B, Meissner J, Findenegg GH. Aggregation of silica nanoparticles directed by adsorption of lysozyme. Langmuir. 2011;27(16):9823–9833. doi:10.1021/la201898v21728288
   PubMedGoogle Scholar
• Meder F, Daberkow T, Treccani L, et al. Protein adsorption on colloidal alumina particles functionalized with amino, carboxyl, sulfonate and phosphate groups. Acta Biomater. 2012;8(3):1221–1229. doi:10.1016/j.actbio.2011.09.01421963406
   PubMedGoogle Scholar
• Klose T, Welzel PB, Werner C. Protein adsorption from flowing solutions on pure and maleic acid copolymer modified glass particles. Colloids Surf B Biointerfaces. 2006;51(1):1–9. doi:10.1016/j.colsurfb.2006.04.01916797943
   PubMedGoogle Scholar
• Elliott Donaghue I, Tator CH, Shoichet MS. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord. Biomater Sci. 2015;3(1):65–72. doi:10.1039/c4bm00311j26214190
   PubMedGoogle Scholar
• Machalinska A, Lubinski W, Klos P, et al. Sodium iodate selectively injuries the posterior pole of the retina in a dose-dependent manner: morphological and electrophysiological study. Neurochem Res. 2010;35(11):1819–1827. doi:10.1007/s11064-010-0248-620725778
   PubMedGoogle Scholar
• Ding HM, Ma YQ. Computer simulation of the role of protein corona in cellular delivery of nanoparticles. Biomaterials. 2014;35(30):8703–8710. doi:10.1016/j.biomaterials.2014.06.03325005681
   PubMedGoogle Scholar